Diversified Consumer Services
Company Overview of The University of Pennsylvania
University of Pennsylvania is an educational institution offering graduate, undergraduate, professional, summer courses, and distance learning programs in fields such as law, medicines, communication, and dental medicine. The schools of the university include School of Arts and Sciences; Annenberg School for Communication; School of Dental Medicine; Graduate School of Education; School of Engineering and Applied Science; Graduate School of Fine Arts; Law School; School of Medicine; School of Nursing; School of Social Work; School of Veterinary Medicine; and Wharton School. University of Pennsylvania was established in 1740 and is based in Philadelphia, Pennsylvania. The university has endowm...
3451 Walnut Street
Philadelphia, PA 19104
Founded in 1740
Key Executives for The University of Pennsylvania
Dean of the School of Design
Associate, Licensing and New Business Start-Up at Center for Technology Transfer
Compensation as of Fiscal Year 2014.
The University of Pennsylvania Key Developments
University of Pennsylvania and University of Georgia Scientists Wins New Contract from the National Institutes of Allergy and Infectious Disease
Dec 18 14
A genome database team led by University of Pennsylvania and University of Georgia scientists has been awarded a new contract from the National Institutes of Allergy and Infectious Disease worth $4.3 million in 2014 to 2015. Assuming annual renewal, this five-year award is expected to total $23.4 million. The team has been responsible for developing genome database resources for microbial pathogens, including the parasites responsible for malaria, sleeping sickness, toxoplasmosis and many other important diseases. The new contract ensures work will continue on the Eukaryotic Pathogen Genomics Database known as EuPathDB to provide the global scientific community with free access to a wealth of genomic data related to microbial pathogens important to human health and bio-security. EuPathDB expedites biomedical research in the lab, field and clinic, enabling the development of innovative diagnostics, therapies and vaccines. The latest contract is the third time that NIH has awarded support to EuPathDB, building on previous contracts issued in 2004 and 2009 as well as prior grant funding from the NIH and the Burroughs Wellcome Fund.
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria
Oct 21 14
Inovio Pharmaceuticals, Inc. announced the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune. The group will develop DNA-based monoclonal antibodies (mAbs) for infectious disease treatment. DARPA is an agency of the US Department of Defense that creates and supports novel technologies important for national security. Together, the three organizations will develop and assess the DNA mAbs in preclinical studies using technology developed by Penn and licensed by Inovio. The collaboration will focus on three disease areas -- influenza virus, Pseudomonas aeruginosa and Staphylococcus aureus. This collaboration aims to demonstrate that the DNA plasmids containing optimized DNA sequences encoded to generate disease-specific mAbs can activate sufficient quantities of specific antibodies in the body to be protective against a pathogen challenge. Using the capabilities and advantages of synthetic DNA plasmids delivered using electroporation, the team will construct and evaluate multiple DNA mAbs.
The University of Pennsylvania Presents at Stem Cell Meeting on the Mesa Partnering Forum, Oct-08-2014 05:45 PM
Oct 4 14
The University of Pennsylvania Presents at Stem Cell Meeting on the Mesa Partnering Forum, Oct-08-2014 05:45 PM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Carl June, M.D., Richard W. Vague Professor in Immunotherapy, Perelman School of Medicine.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|